REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 270 filers reported holding REPLIGEN CORP in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,831,996 | +14.5% | 30,388 | +1.9% | 1.18% | +20.2% |
Q2 2023 | $4,218,762 | -10.9% | 29,823 | +6.0% | 0.98% | -14.5% |
Q1 2023 | $4,736,135 | +42.3% | 28,131 | +43.1% | 1.15% | +35.3% |
Q4 2022 | $3,329,143 | -27.5% | 19,663 | -19.8% | 0.85% | -30.8% |
Q3 2022 | $4,589,000 | +39.4% | 24,524 | +21.0% | 1.23% | +36.2% |
Q2 2022 | $3,292,000 | -15.6% | 20,273 | -2.2% | 0.90% | -2.5% |
Q1 2022 | $3,899,000 | -29.5% | 20,727 | -0.7% | 0.93% | -24.7% |
Q4 2021 | $5,527,000 | -3.9% | 20,868 | +4.8% | 1.23% | -11.3% |
Q3 2021 | $5,754,000 | +10.2% | 19,912 | -23.9% | 1.39% | +9.0% |
Q2 2021 | $5,222,000 | +5.9% | 26,158 | +3.1% | 1.27% | -6.4% |
Q1 2021 | $4,931,000 | +32.7% | 25,364 | +30.8% | 1.36% | +20.4% |
Q4 2020 | $3,716,000 | -13.4% | 19,394 | -33.3% | 1.13% | -21.2% |
Q3 2020 | $4,292,000 | +28.6% | 29,091 | +7.7% | 1.43% | +19.5% |
Q2 2020 | $3,338,000 | -14.4% | 27,005 | -33.1% | 1.20% | -35.5% |
Q1 2020 | $3,900,000 | -1.6% | 40,394 | -5.8% | 1.86% | +64.8% |
Q4 2019 | $3,965,000 | +19.6% | 42,860 | -0.9% | 1.13% | +14.4% |
Q3 2019 | $3,315,000 | +8.9% | 43,229 | +22.1% | 0.98% | +17.7% |
Q2 2019 | $3,043,000 | +43.3% | 35,399 | -1.5% | 0.84% | +44.1% |
Q1 2019 | $2,123,000 | +11.5% | 35,941 | -0.5% | 0.58% | -14.1% |
Q4 2018 | $1,904,000 | -4.1% | 36,105 | +0.9% | 0.68% | +26.6% |
Q3 2018 | $1,985,000 | -12.9% | 35,787 | -26.1% | 0.53% | -18.1% |
Q2 2018 | $2,279,000 | +31.7% | 48,458 | +1.3% | 0.65% | +20.5% |
Q1 2018 | $1,730,000 | +9.8% | 47,818 | +10.1% | 0.54% | +30.4% |
Q4 2017 | $1,576,000 | -6.1% | 43,445 | -0.8% | 0.42% | -9.2% |
Q3 2017 | $1,679,000 | -7.7% | 43,816 | -0.2% | 0.46% | -9.5% |
Q2 2017 | $1,820,000 | +128.4% | 43,909 | +93.8% | 0.50% | +127.5% |
Q1 2017 | $797,000 | +14.7% | 22,655 | +0.5% | 0.22% | +11.0% |
Q4 2016 | $695,000 | +3.7% | 22,537 | +1.6% | 0.20% | +3.6% |
Q3 2016 | $670,000 | +10.2% | 22,182 | -0.2% | 0.19% | +3.2% |
Q2 2016 | $608,000 | -48.5% | 22,218 | -49.5% | 0.19% | -50.1% |
Q1 2016 | $1,180,000 | -7.3% | 44,015 | -2.2% | 0.38% | -3.8% |
Q4 2015 | $1,273,000 | -6.1% | 45,005 | -7.6% | 0.39% | -2.7% |
Q3 2015 | $1,356,000 | – | 48,700 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |